Infectious Disease · PANCE / PANRE

Malaria

Mosquito-borne Plasmodium infection; P. falciparum causes most morbidity and severe disease — empiric treatment guided by species and severity.

Also known as: malaria, Plasmodium falciparum, Plasmodium vivax, P. ovale, P. malariae, P. knowlesi

Overview

Parasitic illness caused by Plasmodium protozoa transmitted by female Anopheles mosquitoes. Five species infect humans: P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi (Southeast Asia, zoonotic). P. falciparum and P. knowlesi cause the most severe disease.

Epidemiology

Worldwide ~240 million cases and ~600,000 deaths annually (WHO 2022), predominantly children under 5 in sub-Saharan Africa. ~2,000 imported US cases yearly. Sub-Saharan Africa: P. falciparum dominant. Asia/Americas: P. vivax common.

Try two board-style Malaria questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1Infectious DiseaseMedium
A 55-year-old man presents 10 days after returning from a 3-week trip to sub-Saharan Africa. He reports 4 days of high fevers with chills and rigors occurring at irregular intervals, myalgias, and headache. He did not take malaria chemoprophylaxis. Exam shows temperature 39.5C and mild splenomegaly. Labs show thrombocytopenia (platelets 78 K/uL). Giemsa-stained thick and thin blood smears reveal multiple ring-form trophozoites within single erythrocytes and crescent-shaped (banana-shaped) gametocytes. Which of the following is the most likely diagnosis?
  • APlasmodium ovale
  • BPlasmodium malariae
  • CPlasmodium vivax
  • DPlasmodium falciparum
Reveal answer & full explanation
Correct answer: D — Plasmodium falciparum
  • APlasmodium ovale
  • BPlasmodium malariae
  • CPlasmodium vivax
  • DPlasmodium falciparum

Why Plasmodium falciparum is correct

  • Smear shows multiple ring-form trophozoites within a single erythrocyte — this finding is not seen in other Plasmodium species
  • Crescent-shaped (banana-shaped) gametocytes are pathognomonic for P. falciparum
  • P. falciparum is the most dangerous species and can cause cerebral malaria, acute respiratory distress syndrome (ARDS), and acute kidney injury (AKI)

Why the others are wrong

  • A) Plasmodium ovale — does not produce banana-shaped gametocytes or multiple rings per RBC
  • B) Plasmodium malariae — does not produce banana-shaped gametocytes or multiple rings per RBC
  • C) Plasmodium vivax — does not produce banana-shaped gametocytes or multiple rings per RBC

Additional high-yield points

  • Treatment of uncomplicated P. falciparum: artemisinin-based combination therapy (ACT), specifically artemether-lumefantrine
  • Severe or cerebral P. falciparum: IV artesunate, which is superior to quinine per the AQUAMAT trial
  • P. falciparum is chloroquine-resistant in most of Africa and Asia
Question 2Infectious DiseaseMedium
A 34-year-old man presents with 5 days of fever, headache, and myalgias that began shortly after returning from a 3-week trip to rural Nigeria, where he did not take chemoprophylaxis. Temperature is 39.4°C (102.9°F), and he appears fatigued with mild scleral icterus and splenomegaly. Laboratory studies show hemoglobin of 10.1 g/dL, platelets of 88,000/µL, and an elevated LDH. Which of the following is the most appropriate next diagnostic test?
  • ABlood plus stool cultures
  • BDengue NS1 with IgM serology
  • CHIV-1 RNA quantitative test
  • DThick and thin blood smears
Reveal answer & full explanation
Correct answer: D — Thick and thin blood smears
  • ABlood plus stool cultures
  • BDengue NS1 with IgM serology
  • CHIV-1 RNA quantitative test
  • DThick and thin blood smears

Why Thick and thin blood smears is correct

  • Fever in a traveler returning from sub-Saharan Africa is malaria until proven otherwise, and this vignette (fever, thrombocytopenia, hemolytic anemia with elevated LDH, scleral icterus, splenomegaly) is classic for Plasmodium infection.
  • Giemsa-stained thick and thin smears are the diagnostic gold standard: the thick smear maximizes sensitivity for detecting parasites, while the thin smear allows species identification and quantitation of parasitemia, which guides severity classification and therapy.
  • Smears must be obtained urgently, within hours rather than days, and repeated over 12-24 hours (up to 3 sets) before malaria can be excluded, because parasitemia fluctuates with the erythrocytic cycle. A rapid antigen test can supplement but does not replace the smear.

Why the others are wrong

  • Blood plus stool cultures: This is the workup for typhoid fever, which can mimic malaria with fever and abdominal symptoms but classically shows stepwise fever, relative bradycardia, and rose spots; cultures do not detect a blood-borne parasite and would delay the time-critical malaria diagnosis.
  • Dengue NS1 with IgM serology: Dengue is co-endemic and also causes fever and thrombocytopenia, but it features retro-orbital pain and rash rather than hemolytic anemia, jaundice, and splenomegaly; pursuing it first risks missing potentially fatal falciparum malaria.
  • HIV-1 RNA quantitative test: Acute HIV is tested when there is a recent high-risk exposure, which is absent here; it does not explain the hemolytic picture and is not the priority in a febrile returning traveler from an endemic area.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Malaria outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Travel to endemic areas without chemoprophylaxis
  • Inadequate vector avoidance (no bed nets, no DEET, dawn/dusk exposure)
  • Pregnancy (severe malaria more common; placental sequestration)
  • Asplenia (poor parasite clearance)
  • Sickle cell trait protects against severe P. falciparum

Pathophysiology

Sporozoites injected by mosquito infect hepatocytes (exoerythrocytic stage). After 1-2 weeks, merozoites release into the bloodstream and invade RBCs (erythrocytic stage). Repeated cycles of RBC rupture cause cyclic fever paroxysms. P. falciparum infects RBCs of all ages and causes cytoadherence to endothelium → microvascular sequestration → cerebral malaria, ARDS, AKI, severe anemia. P. vivax and P. ovale form dormant liver hypnozoites that can reactivate months to years later.

Clinical presentation

Symptoms

  • Incubation: P. falciparum 7-30 days; P. vivax/ovale weeks to months (or years for relapse)
  • Cyclic fever paroxysms (cold stage → hot stage → diaphoretic stage); classic 48-hour cycle (vivax, ovale) or 72-hour (malariae); P. falciparum often continuous or irregular
  • Headache, myalgia, fatigue, abdominal pain, nausea
  • Severe malaria (P. falciparum): impaired consciousness, seizures (cerebral malaria), respiratory distress, jaundice, oliguria, severe anemia, hypoglycemia, shock

Signs / physical exam

  • Fever (may be high), pallor, hepatosplenomegaly, jaundice
  • Tachypnea (compensatory for metabolic acidosis)
  • Petechiae rare (unlike dengue)
  • Coma, decerebrate posturing in cerebral malaria

Classic findings

A returning traveler from sub-Saharan Africa with cyclic fevers, thrombocytopenia, and elevated LDH — malaria until proven otherwise. Severe disease in non-immune travelers can present with shock, AKI, and ARDS.

Differential diagnosis

  • Typhoid fever — Stepwise fever, relative bradycardia, rose spots, abdominal pain; blood/stool culture
  • Dengue / chikungunya / Zika — Endemic overlap; thrombocytopenia, retro-orbital pain, rash; serology/PCR
  • Leptospirosis — Freshwater exposure, calf myalgia, conjunctival suffusion, AKI, jaundice
  • Viral hemorrhagic fevers (Ebola, Lassa) — Outbreak setting, bleeding, multiorgan failure; strict isolation
  • Acute HIV — Recent high-risk exposure; RNA viral load
  • Babesiosis — Tick exposure (Ixodes), hemolytic anemia, intra-erythrocytic ring forms similar to P. falciparum; co-endemic in Northeast US
  • Influenza, other viral illnesses — Common; presents similarly early — always ask about travel

Diagnostic workup

Diagnostic criteria

Positive blood smear or RDT in a patient with consistent clinical syndrome. Severe malaria per WHO: impaired consciousness, prostration, multiple convulsions, acidosis, hypoglycemia, severe anemia (Hgb <7 adults), AKI, jaundice, pulmonary edema, abnormal bleeding, shock, hyperparasitemia (≥5% in non-immune).

Labs

  • Thick and thin blood smears (Giemsa) — thick for sensitivity, thin for species and parasitemia quantitation; obtain 3 sets over 12-24 hours before excluding diagnosis
  • Rapid diagnostic test (RDT, BinaxNOW Malaria) for antigen detection — useful in emergency settings
  • PCR for species confirmation (especially mixed infections)
  • G6PD activity before primaquine/tafenoquine (hemolysis risk)
  • CBC (hemolytic anemia, thrombocytopenia), CMP (AKI, transaminitis), bilirubin (indirect hyperbilirubinemia), glucose (hypoglycemia in severe disease), lactate, coagulation

Imaging

  • CXR if pulmonary symptoms (rule out ARDS)
  • CT/MRI brain if cerebral malaria features

Diagnostic algorithm

SpeciesPeriodicityHypnozoite?Severe Disease?First-line Therapy
P. falciparumIrregular / 36-48 hNoYes (most severe)Artemether-lumefantrine; IV artesunate if severe
P. vivax48 h (tertian)YesRareChloroquine + primaquine (or tafenoquine)
P. ovale48 h (tertian)YesRareChloroquine + primaquine
P. malariae72 h (quartan)NoRareChloroquine
P. knowlesi24 hNoYesArtemisinin-based therapy
Plasmodium species comparison: clinical features and first-line treatment.

Treatment

First-line

  • Uncomplicated P. falciparum (or unidentified species, chloroquine-resistant areas):
  • • Artemether-lumefantrine (Coartem) PO × 3 days — first-line in US for uncomplicated falciparum
  • • Atovaquone-proguanil (Malarone) PO × 3 days
  • • Quinine sulfate + doxycycline (or tetracycline/clindamycin) × 7 days
  • Severe malaria:
  • • IV artesunate (CDC stocks, available emergently 24/7) — initial dose 2.4 mg/kg, repeat at 12 and 24 h, then daily; transition to oral once stable
  • • Followed by full course of oral artemether-lumefantrine or atovaquone-proguanil
  • Chloroquine-sensitive infections (P. malariae, P. ovale, P. vivax from chloroquine-sensitive areas):
  • • Chloroquine phosphate PO × 3 days
  • Hypnozoite eradication (P. vivax, P. ovale):
  • • Primaquine 30 mg base daily × 14 days (after G6PD testing); single-dose tafenoquine 300 mg alternative

Second-line / adjunct

  • Chemoprophylaxis options for travelers:
  • • Atovaquone-proguanil daily (starting 1-2 days before travel, continuing 7 days after return)
  • • Doxycycline daily (1-2 days before, continuing 4 weeks after — also covers leptospirosis, rickettsial illness)
  • • Mefloquine weekly (start 2 weeks before; avoid with seizures, psychiatric disease)
  • • Tafenoquine weekly (3 days before, weekly during, single dose after; requires G6PD testing)
  • Exchange transfusion historically considered for hyperparasitemia (>10%) — no longer routinely recommended with IV artesunate

Complications

  • Cerebral malaria (impaired consciousness, seizures, death) — leading cause of mortality
  • Severe hemolytic anemia, blackwater fever (massive intravascular hemolysis with hemoglobinuria)
  • ARDS, AKI requiring dialysis
  • Hypoglycemia (especially in pregnancy, children, quinine-treated patients)
  • Splenic rupture (especially P. vivax)
  • Relapse months to years later (P. vivax, P. ovale)
  • Adverse fetal outcomes in pregnancy (low birth weight, prematurity, stillbirth)

PANCE pearls

  • Fever in a returned traveler is malaria until proven otherwise — obtain smears within hours, not days.
  • Always check G6PD before primaquine or tafenoquine (severe hemolysis if deficient).
  • IV artesunate is now standard for severe malaria worldwide and is available emergently from the CDC for US clinicians.
  • Pregnant patients with malaria are at extreme risk — early specialist involvement; quinine + clindamycin historically used in first trimester though artemether-lumefantrine increasingly used.
  • P. vivax and P. ovale hypnozoites require primaquine/tafenoquine for radical cure to prevent relapse months later.

References

  • WHO 2023 — Guidelines for the treatment of malaria, third edition
  • CDC 2023 — Treatment of Malaria: Guidelines for Clinicians (United States) — CDC Yellow Book/Malaria branch
  • AQUAMAT — Dondorp et al., Artesunate versus quinine in the treatment of severe falciparum malaria in African children (Lancet 2010)

Practice Infectious Disease questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.